Sanofi to produce Moderna’s COVID-19 vaccine

Sanofi entered an agreement April 26 to help manufacture 200 million doses of Moderna’s COVID-19 vaccine, beginning in September.

Advertisement

The drugmaker will provide fill and finish manufacturing capacity, which will take place at its facility in Ridgefield, N.J. 

Sanofi has now committed to manufacturing all three COVID-19 vaccines authorized for emergency use in the U.S., as the drugmaker has also signed agreements to produce the vaccines designed by Pfizer and Johnson & Johnson.

More articles on pharmacy:
8 key COVID-19 vaccine administration errors
COVID-19 vaccine surplus rose by 30% in 2 weeks
US resumes use of J&J’s COVID-19 vaccine

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.